Actively Recruiting
Nurse-led Acceptance-based Healthy Lifestyles Program for Community-dwelling Patients With Pneumoconiosis: A Waitlist Pilot Randomized Controlled Trial
Led by Chinese University of Hong Kong · Updated on 2025-04-13
80
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate an acceptance-based educational program designed for patients with pneumoconiosis, a condition characterized by symptoms like cough and shortness of breath that can lead to psychological issues such as depression and anxiety. Avoidance of daily activities due to symptoms may cause lung function decline and increase risks of stroke and heart failure. The study is a pilot randomized controlled trial with two groups, focusing on the effects and feasibility of the program in improving health outcomes. The study involves 80 participants randomly assigned to either an intervention group or a waitlist control group in equal numbers. The intervention consists of a 6-week group-based program delivered in four biweekly 60-minute face-to-face sessions. These sessions cover knowledge about pneumoconiosis, exercises to maintain lung function, healthy diet, and home safety. The intervention group receives the program first during weeks 1 to 6, followed by the waitlist control group who receive it during weeks 8 to 14. Participants will be assessed at baseline, week 6, and week 14 for psychological health, healthy lifestyle practices, and cardiometabolic indicators such as blood pressure, weight, waist circumference, and glycated hemoglobin. The program's feasibility will be evaluated through participant interviews. Data will be analyzed statistically to understand the program's impact and inform future integration of acceptance-based interventions for chronic lung diseases. The total study duration includes initial assessment, intervention periods, and follow-up evaluations.
CONDITIONS
Brief Title
Acceptance-based Healthy Lifestyles Program for Patients With Pneumoconiosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ethnic Chinese who is able to read and speak Chinese
- Adults aged 18 or over
- Taking compensation for pneumoconiosis
You will not qualify if you...
- Mental, visual, hearing, or cognitive impairments with regular medical follow-ups and treatment
- Unable to give written consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 weeks
Participants attend 4 biweekly 60-minute face-to-face interactive workshops covering pneumoconiosis knowledge, exercise to maintain lung function, healthy diet, and home safety.
4 biweekly visits (in-person)
Duration - 8 weeks
Participants either wait before starting the program or are monitored after completing the program with assessments at weeks 6 and 14.
2 visits at weeks 6 and 14 (in-person)
Trial Site Locations
Total: 1 location
1
PMAA
Hong Kong, Hong Kong
Actively Recruiting
Research Team
H
Hon Lon Tam, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here